Moderna Reports Major Miss on Q3 Earnings

Moderna reported a massive miss on revenue in its Q3 earnings, taking in $5 billion versus the expected $6.21 billion despite sales of the COVID-19 vaccine. The pharmaceutical giant's stock dropped sharply on the news.
More Videos
CES 2025: Top Tech to Watch
Jason Hiner, Editor in Chief of ZDNET, breaks down the best tech that came out of CES 2025, including Nvidia's Cosmos, New TV Tech, Roborok Saros Z70 and more.
Load More